title: Treatment of erectile impotence in renal transplant patients with intracavernosal vasoactive drugs.
authors.affiliation: Department of Urology, Hospital 12 de Octubre, Facultad de Medicina, Universidad Complutense de Madrid, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Rodriguez Antolin
authors.forename: J M
authors.initials: JM
authors.lastname: Morales
authors.forename: A
authors.initials: A
authors.lastname: Andrés
authors.forename: T
authors.initials: T
authors.lastname: Fernández Aparicio
authors.forename: R
authors.initials: R
authors.lastname: Díaz González
authors.forename: M
authors.initials: M
authors.lastname: Pamplona
authors.forename: E
authors.initials: E
authors.lastname: Alvarez
mesh_terms: D000527:Alprostadil / Q000008:administration & dosage / Q000627:therapeutic use*; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology; D004958:Estradiol / Q000097:blood; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology*; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage / Q000627:therapeutic use*; D010410:Penile Erection / Q000187:drug effects*; D011388:Prolactin / Q000097:blood; D006435:Renal Dialysis; D012189:Retrospective Studies; D013739:Testosterone / Q000097:blood; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D014662:Vasoconstrictor Agents; D013739:Testosterone; D004958:Estradiol; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D010208:Papaverine; D000527:Alprostadil